Avoid the trap of eating less but eating poorly
GLP-1 receptor activation modulates dopamine signaling in ways that appear beneficial rather than disruptive
These medications target receptors in the brain specifically in the hypothalamus and hindbrain to curb appetite and reduce constant thoughts about food, often referred to as "food noise." "Lots of people describe it as decreasing food noise, which means how much you think about food and how much you crave different foods." Evan Nadler, MD, MBA, Adjunct Associate Professor, George Washington University Myth 5: GLP-1 Medications Are Only for Type 2 Diabetes Although GLP-1 medications were initially created to manage diabetes, they now have FDA approval for chronic weight management in people without diabetes
your trial team or local pharmacy can advise on the most appropriate route
The sequential nature of these steps MHRA authorisation, followed by NICE appraisal, followed by NHS commissioning means that routine NHS access to retatrutide, should it ultimately be approved, would follow a pathway similar to that of other recently authorised weight management medicines
I'm happy
